Page last updated: 2024-12-05

lauric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Lauric acid, also known as dodecanoic acid, is a saturated fatty acid with the formula CH3(CH2)10COOH. It is a white, waxy solid at room temperature. Lauric acid is found in a variety of plant and animal fats, particularly in coconut oil and palm kernel oil. It is also a component of human breast milk. Lauric acid is used in the production of soaps, detergents, cosmetics, and pharmaceuticals. Lauric acid is also being studied for its potential health benefits, including its antimicrobial and antiviral properties. Lauric acid has been shown to be effective against a variety of bacteria, viruses, and fungi. It is also being investigated for its potential to reduce inflammation and improve cardiovascular health.'

dodecanoic acid : A straight-chain, twelve-carbon medium-chain saturated fatty acid with strong bactericidal properties; the main fatty acid in coconut oil and palm kernel oil. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3893
CHEMBL ID108766
CHEBI ID30805
SCHEMBL ID5895
MeSH IDM0096079

Synonyms (147)

Synonym
AC-16451
MLS002177807
smr001253907
wln: qv11
hydrofol acid 1255
univol u-314
wecoline 1295
laurostearic acid
ninol aa62 extra
dodecylic acid
n-dodecanoic acid
nsc5026 ,
1-undecanecarboxylic acid
c-1297 ,
hydrofol acid 1295
nsc-5026
duodecylic acid
aliphat no. 4
vulvic acid
ABL ,
dodecoic acid
duodecyclic acid
c12:0
undecane-1-carboxylic acid
laurinsaeure
ch3-[ch2]10-cooh
CHEBI:30805 ,
DAO ,
hystrene 9512
LAU ,
dodecanoic acid (lauric acid)
inchi=1/c12h24o2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h2-11h2,1h3,(h,13,14
NCGC00090919-02
NCGC00090919-01
hsdb 6814
lauric acid (natural)
ai3-00112
lauric acid, pure
einecs 205-582-1
brn 1099477
fema no. 2614
ccris 669
143-07-7
dodecanoic acid
dodecylcarboxylate
lauric acid
C02679
dodecanoic acid, >=99% (gc/titration)
lauric acid, >=98%, fcc, fg
lauric acid, natural, >=98%, fcc, fg
dodecanoic acid, 98%
DB03017
LMFA01010012
NCIOPEN2_009480
MLS002415737
76C2A2EB-E8BA-40A6-8032-40A98625ED7B
AKOS000277433
dodecanoic acid (lauric acid)
dodecanoic (lauric) acid
prifrac 2920
BMSE000509
CHEMBL108766
dodecanoic acid anion
FT-0695772
L0011
fatty acid 12:0
fa 12:0
A808010
NCGC00090919-03
ec 205-582-1
unii-1160n9nu9u
4-02-00-01082 (beilstein handbook reference)
1160n9nu9u ,
dtxsid5021590 ,
cas-143-07-7
dtxcid801590
tox21_303010
NCGC00256486-01
tox21_202149
NCGC00259698-01
HMS2268C14
S4726
STL281860
FT-0625572
lauric acid [mi]
lauric acid [inci]
lauric acid (constituent of saw palmetto) [dsc]
lauric acid [fhfi]
lauric acid [fcc]
lauric acid [who-dd]
dodecanoic acid [hsdb]
lauric acid [usp-rs]
3UIL
gtpl5534
SCHEMBL5895
dodecanic acid
lunac l 70
philacid 1200
acide laurique
emery 651
emery 650
D10714
lauric acid (nf)
HMS3649N06
mfcd00002736
dodecanoic acid, purum, >=96.0% (gc)
lauric acid, united states pharmacopeia (usp) reference standard
dodecanoic acid, analytical standard
dodecanoic acid, >=99.5%
lauric acid, european pharmacopoeia (ep) reference standard
lauric acid, pharmaceutical secondary standard; certified reference material
dodecanoic acid, 99%
J-007739
bdbm50180948
nissan naa 122
kortacid 1299
prifac 2920
lunac l 98
univol u 314
edenor c 1298-100
CS-0015078
HY-Y0366
F0001-0507
Q422627
Z104476194
lauric acid, reagent
sr-01000838338
SR-01000838338-3
A16350
STR08039
lauric-acid
CCG-266587
BP-27913
n-dodecanoicacid
dodecanoicacid
EN300-19951
8000-62-2
lauric acid (usp-rs)
203714-07-2
laurinsaure
lauric acid (constituent of saw palmetto)
ch3-(ch2)10-cooh
naa 122
naa 312
7632-48-6
hydrofol acid 1255 or 1295
nuvail

Research Excerpts

Overview

Lauric acid is a 12-carbon medium chain fatty acid (MCFA) found abundantly in coconut oil or palm kernel oil and it comes with multiple beneficial effects. Lauric acid serves as an endogenous substrate for the cytochrome P450 enzyme CYP4A11.

ExcerptReferenceRelevance
"Lauric acid (LA) is a crucial medium-chain fatty acid (MCFA) that has many beneficial effects on humans and animals. "( Integrating Serum Metabolome and Gut Microbiome to Evaluate the Benefits of Lauric Acid on Lipopolysaccharide- Challenged Broilers.
Li, Q; Liu, J; Liu, Y; Wang, Y; Wu, Y; Xu, Y; Yang, C; Yu, Y; Zhang, R, 2021
)
2.29
"Lauric acid is a 12-carbon medium chain fatty acid (MCFA) found abundantly in coconut oil or palm kernel oil and it comes with multiple beneficial effects."( Lauric acid alleviates insulin resistance by improving mitochondrial biogenesis in THP-1 macrophages.
Chew, CH; Choo, QC; Muhammad, TST; Tham, YY, 2020
)
2.72
"Lauric acid is a green derivate that is abundant in some seeds such as coconut oil where it represents the most relevant fatty acid. "( Encapsulation of Thermo-Sensitive Lauric Acid in Silica Shell: A Green Derivate for Chemo-Thermal Therapy in Breast Cancer Cell.
Cascione, M; De Giorgi, ML; De Matteis, V; Leporatti, S; Rinaldi, R, 2019
)
2.24
"Lauric acid serves as an endogenous substrate for the cytochrome P450 enzyme CYP4A11. "( Determination of CYP4A11-catalyzed lauric acid 12-hydroxylation by high-performance liquid chromatography with radiometric detection.
Chang, TK; Crespi, CL; Waxman, DJ, 2006
)
2.05

Effects

Lauric acid has a broad spectrum of anti-microbiological activities against enveloped viruses and various bacteria. It might be useful to protect against microbial infection and control the balance and distribution of bacteria in human gut microbiota.

ExcerptReferenceRelevance
"Lauric acid (LA) has a broad spectrum of anti-microbiological activities against enveloped viruses and various bacteria, and might be useful to protect against microbial infection and control the balance and distribution of bacteria in human gut microbiota. "( Measuring the Antimicrobial Activity of Lauric Acid against Various Bacteria in Human Gut Microbiota Using a New Method.
Hirano, R; Kurihara, S; Matsue, M; Mori, Y; Nagase, S; Ogai, K; Ogura, K; Okamoto, S; Sugiyama, Y, 2019
)
2.22
"Lauric acid (LA) has a broad spectrum of anti-microbiological activities against enveloped viruses and various bacteria, and might be useful to protect against microbial infection and control the balance and distribution of bacteria in human gut microbiota. "( Measuring the Antimicrobial Activity of Lauric Acid against Various Bacteria in Human Gut Microbiota Using a New Method.
Hirano, R; Kurihara, S; Matsue, M; Mori, Y; Nagase, S; Ogai, K; Ogura, K; Okamoto, S; Sugiyama, Y, 2019
)
2.22
"Lauric acid (LA) has antimicrobial effects and the potential to replace antibiotics in feeds to prevent postweaning diarrhea and increase overall swine productivity. "( The Effects of Lauric Acid on IPEC-J2 Cell Differentiation, Proliferation, and Death.
Huang, J; Li, J; Yang, H; Yang, Y; Yin, Y, 2020
)
2.35
"Lauric acid (LA) has been implicated in the prevention/treatment of obesity. "( Dietary Supplementation of Lauric Acid Alleviates the Irregular Estrous Cycle and the Impaired Metabolism and Thermogenesis in Female Mice Fed with High-Fat Diet (HFD).
Chen, L; Duan, C; Gao, P; Jiang, Q; Lai, X; Li, F; Ling, M; Shu, G; Song, M; Wang, L; Wang, S; Yang, Q; Yang, X; Zhang, F; Zhu, X, 2020
)
2.3

Actions

ExcerptReferenceRelevance
"Lauric acid did not inactivate virion infectivity neither interacted with the cell to induce a state refractory to virus infection."( Effect of fatty acids on arenavirus replication: inhibition of virus production by lauric acid.
Bartolotta, S; Candurra, NA; Damonte, EB; García, CC, 2001
)
1.26

Treatment

Lauric acid can directly and potently activate ketogenesis in KT-5 astrocytes. Treatment showed significant inhibition of prostate enlargement and protection of histoarchitecture of prostate when compared with positive control group.

ExcerptReferenceRelevance
"The lauric acid treatments increased the total ketone body concentration in the cell culture supernatant to a greater extent than oleic acid, suggesting that lauric acid can directly and potently activate ketogenesis in KT-5 astrocytes."( Lauric Acid Stimulates Ketone Body Production in the KT-5 Astrocyte Cell Line.
Aoyama, T; Honda, K; Inai, M; Nishimura, S; Nonaka, Y; Takagi, T; Terada, S; Urashima, S, 2016
)
2.36
"Lauric acid/myristic acid treatment showed significant inhibition of prostate enlargement and protection of histoarchitecture of prostate when compared with positive control group."( Lauric acid and myristic acid prevent testosterone induced prostatic hyperplasia in rats.
Patil, AA; Veeresh Babu, SV; Veeresh, B; Warke, YB, 2010
)
2.52
"Treatment with lauric acid preserved the testicular and epididymal histomorphometry, along with the significant improvements in sperm characteristics."( Lauric acid improves hormonal profiles, antioxidant properties, sperm quality and histomorphometric changes in testis and epididymis of streptozotocin-induced diabetic infertility rats.
Anuar, NS; Azmi, NAS; Maznan, MAF; Myrzakozha, D; Raoof, RA; Samsulrizal, N; Shafie, SA; Zin, NSNM, 2023
)
2.69

Toxicity

ExcerptReferenceRelevance
"To develop the safe absorption-enhancing formulation attenuating the local toxicity caused by an absorption enhancer, sodium laurate (C12), the effects of amino acids on the local toxicity by C12 were examined in rats."( Amino acids protect epithelial cells from local toxicity by absorption enhancer, sodium laurate.
Endo, Y; Higaki, K; Kimura, T; Ogawara, K; Sone, M; Yata, T, 2001
)
0.31
" Thus, the different toxicities may permit the selection of agents that enhance gene transfer with minimal adverse effects."( Safety and efficiency of modulating paracellular permeability to enhance airway epithelial gene transfer in vivo.
Coyne, CB; Gavett, SH; Haykal-Coates, N; Johnson, LG; Vanhook, MK, 2003
)
0.32
"To develop the safe formulation that can safely improve bioavailability of poorly absorbable drugs and that is practically available, we prepared the suppositories of rebamipide, a poorly soluble and poorly absorbable antiulcer drug, by employing the combinatorial use of sodium laurate (C12), an absorption enhancer, with taurine (Tau) or L-glutamine (L-Gln), an adjuvant exerting the cytoprotective action."( Development of suppository formulation safely improving rectal absorption of rebamipide, a poorly absorbable drug, by utilizing sodium laurate and taurine.
Higaki, K; Kamada, N; Kimura, T; Minami, T; Miyake, M; Mukai, T; Odomi, M; Ogawara, K; Oka, Y; Toguchi, H, 2004
)
0.32
" Therefore suppressing the potential local toxicity would lead to the successful development of safe preparations with improved absorption using adjuvants."( [Safe improvement of drug absorption by combinatorial use of sodium laurate with amino acids: cytoprotection by amino acids and its mechanisms].
Higaki, K, 2007
)
0.34
"Vizantin, 6,6'-bis-O-(3-nonyldodecanoyl)-α,α'-trehalose, was developed as a safe immunostimulator on the basis of a structure-activity relationship (SAR) study with trehalose 6,6'-dicorynomycolate (TDCM)."( Development of vizantin, a safe immunostimulant, based on the structure-activity relationship of trehalose-6,6'-dicorynomycolate.
Himeno, S; Imagawa, H; Inoue, M; Nagahama, M; Nakano, M; Nishizawa, M; Oda, M; Sakurai, J; Setsu, K; Shibutani, M; Watanabe, N; Yabiku, K; Yamamoto, H, 2013
)
0.39
" No adverse effect was found in the local lymph node assay in mice treated with lauric or myristic acid."( Clinical safety of lauric acid for cattle and its in vitro and in vivo efficacy against Rhipicephalus microplus.
Borges, FA; Carollo, CA; Conde, MH; Dos Santos, LB; Favero, FC; Freitas, MG; Santos-Zanuncio, VS, 2020
)
0.89

Pharmacokinetics

ExcerptReferenceRelevance
" Compared with oral administration, maximum plasma concentration (Cmax) was significantly lower, and time to reach Cmax (Tmax) delayed with all formulated tenoxicam TDS."( Pharmacokinetics of formulated tenoxicam transdermal delivery systems.
Chun, I; Gwak, H; Kang, E; Kim, T, 2008
)
0.35

Compound-Compound Interactions

The objective of this study was to investigate the in vitro activities of virgin coconut oil, lauric acid and monolaurin in combination with lactic acid against two strains of Staphylococcus aureus.

ExcerptReferenceRelevance
"The objective of this study was to investigate the in vitro activities of lauric acid and myristylamine in combination with six antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA)."( In vitro activity of lauric acid or myristylamine in combination with six antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA).
Aoyama, Y; Higuchi, S; Hirakata, Y; Ichikawa, N; Kamihira, S; Kitahara, T; Kohno, S; Nakashima, M; Sasaki, H, 2006
)
0.88
"The objective of this study was to investigate the in vitro activities of virgin coconut oil, lauric acid and monolaurin in combination with lactic acid against two strains of Staphylococcus aureus, ATCC 25923 and an isolate from a pig carcass, by determination of Fractional Bactericidal Concentration Index (FBCI), time-kill method, as well as scanning and transmission electron microscopy."( Activity of virgin coconut oil, lauric acid or monolaurin in combination with lactic acid against Staphylococcus aureus.
Khopaibool, P; Tangwatcharin, P, 2012
)
0.88
"The aim of the paper is to investigate whether changes in the metabolome could explain observed changes in body composition in overweight adults after consumption of butter with high level of medium-chain fatty acids (MCFAs) in combination with casein or whey."( Consumption of Whey in Combination with Dairy Medium-Chain Fatty Acids (MCFAs) may Reduce Lipid Storage due to Urinary Loss of Tricarboxylic Acid Cycle Intermediates and Increased Rates of MCFAs Oxidation.
Amer, B; Bertram, HC; Bohl, M; Clausen, MR; Dalsgaard, TK; Gregersen, S; Hermansen, K; Larsen, MK; Nebel, C; Skov, T; Zheng, H, 2017
)
0.46

Bioavailability

The same patients demonstrated the same patients to be poor estradiol absorbers, different from those encountered with the reservoir patch type. Study of the pharmacokinetics of phenazepam transdermal therapeutic system showed its higher bioavailability in the presence of lauric acid.

ExcerptReferenceRelevance
" After rectal administration in the absence of absorption-promoter, the bioavailability of acyclovir was 37%."( The effect of fatty acids on the rectal absorption of acyclovir in rats.
Itoh, S; Kobayashi, M; Komatsu, T; Sawanoi, M; Suzuki, S; Tanabe, K; Yamazaki, M, 1990
)
0.28
" In the in vivo evaluation using abdominal rat skin, the ethanol/panasate 800 (40/60)-7% (w/w) ethylcellulose gel produced a good feature as a sustained-release preparation, with a relatively high bioavailability (BA) of theophylline, and dose dependency was observed."( Transdermal delivery of theophylline using an ethanol/panasate 800-ethylcellulose gel preparation.
Goto, S; Kim, NS; Kitagawa, K; Lee, CK; Uchida, T, 1995
)
0.29
" The absorption enhancing activity of w/o microemulsions incorporating these lipids was evaluated in the rat using Calcein (MW = 623) a water-soluble and poorly absorbed marker molecule."( Water-in-oil microemulsions containing medium-chain fatty acids/salts: formulation and intestinal absorption enhancement evaluation.
Constantinides, PP; Ellens, H; Owen, AB; Smith, PL; Sturgis, S; Welzel, G; Yiv, SH, 1996
)
0.29
" All matrix patches demonstrated the same patients to be poor estradiol absorbers, different from those encountered with the reservoir patch type, despite an improved estradiol bioavailability with the lauric acid-containing matrix patch."( Estradiol pharmacokinetics after transdermal application of patches to postmenopausal women: matrix versus reservoir patches.
Brion, N; Donazzolo, Y; Lins, R; Reginster, JY, 2000
)
0.49
" In conclusion, the combinatorial use of C12 with Tau or L-Gln could lead to a novel formulation improving the bioavailability of poorly absorbable drugs without any serious local damages."( Combinatorial use of sodium laurate with taurine or L-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages.
Higaki, K; Kimura, T; Minami, T; Miyake, M; Odomi, M; Ogawara, K; Oka, Y; Toguchi, H, 2003
)
0.32
"To develop the safe formulation that can safely improve bioavailability of poorly absorbable drugs and that is practically available, we prepared the suppositories of rebamipide, a poorly soluble and poorly absorbable antiulcer drug, by employing the combinatorial use of sodium laurate (C12), an absorption enhancer, with taurine (Tau) or L-glutamine (L-Gln), an adjuvant exerting the cytoprotective action."( Development of suppository formulation safely improving rectal absorption of rebamipide, a poorly absorbable drug, by utilizing sodium laurate and taurine.
Higaki, K; Kamada, N; Kimura, T; Minami, T; Miyake, M; Mukai, T; Odomi, M; Ogawara, K; Oka, Y; Toguchi, H, 2004
)
0.32
" The rate of absorption was significantly reduced when compared to a simple suspension formulation, a likely combination of retarded erosion of the cubic phase together with hindered drug release from the cubic matrix."( A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugs.
Boyd, BJ; Charman, WN; Kossena, GA; Porter, CJ, 2004
)
0.32
" Study of the pharmacokinetics of phenazepam transdermal therapeutic system showed its higher bioavailability in the presence of lauric acid (f=0."( Effect of lauric acid on transdermal penetration of phenazepam in vivo.
Aleksandrova, AI; Golovenko, NY; Kravchenko, IA; Larionov, VB; Ovcharenko, NV, 2003
)
0.93
" Although Tau tended to attenuate the absorption-enhancing effect of C12, several C12-Tau suppositories kept high bioavailability values, which were much higher than control."( Optimization of suppository preparation containing sodium laurate and taurine that can safely improve rectal absorption of rebamipide.
Higaki, K; Kamada, N; Kato, Y; Kimura, T; Minami, T; Miyake, M; Mukai, T; Odomi, M; Ogawara, K; Oka, Y; Toguchi, H; Yamazaki, H, 2006
)
0.33
" Heating ability of these magnetic fluids was evaluated by calorimetric measurement of specific absorption rate (SAR) at 300 kHz frequency and 15 kA/m field."( Comparative evaluation of heating ability and biocompatibility of different ferrite-based magnetic fluids for hyperthermia application.
Bahadur, D; Banerjee, R; Bellare, J; Giri, J; Mishra, KP; Pradhan, P; Samanta, G; Sarma, HD, 2007
)
0.34
" Such binding plays a crucial role in determining the ADME (absorption, distribution, metabolism, and excretion) and bioavailability of the pollutants."( Combined fluorescence and electrochemical investigation on the binding interaction between organic acid and human serum albumin.
Chen, YM; Guo, LH, 2009
)
0.35
" However, there are a number of factors governing mucosal absorption of drugs and, for drugs with low bioavailability, the reason for the low bioavailability should be analyzed and clarified to improve the bioavailability."( [Analysis of factors governing drug absorption and their improvement].
Kimura, T, 2009
)
0.35
"A nonoral alternative such as transdermal system is desired to improve bioavailability and to maintain a constant and prolonged drug level with reduced frequency of dosing."( Influence of chemical permeation enhancers on transdermal permeation of alfuzosin: an investigation using response surface modeling.
Bindhani, A; Mallick, S; Pattnaik, S; Swain, K, 2011
)
0.37
" The specific absorption rate (SAR) was not greatly affected by concentration."( Tangential Flow Ultrafiltration Allows Purification and Concentration of Lauric Acid-/Albumin-Coated Particles for Improved Magnetic Treatment.
Alexiou, C; Friedrich, RP; Hilger, I; Lee, G; Lyer, S; Nowak, J; Odenbach, S; Pöttler, M; Stapf, M; Tietze, R; Zaloga, J, 2015
)
0.65
" Pelargonic, lauric, myristic, palmitic, margaric, stearic, and oleic acids were suspended in water dissolved in dimethyl sulfoxide (DMSO) or emulsified in water and quillaja saponin to assess how bioavailability impacted Salmonella growth."( Susceptibility of Salmonella enterica Isolates from Tomato Farm Environments to Fatty Acids Naturally Found on Tomato Fruit.
Dev Kumar, G; Micallef, SA, 2017
)
0.46
" Low bioavailability and high frequency of administration in eye drops are major challenges in ocular pharmacotherapy."( Synthesis and evaluation of modified lens using plasma treatment containing timolol-maleate loaded lauric acid-decorated chitosan-alginate nanoparticles for glaucoma.
Alemezadeh, SA; Bagherzadeh, K; Hosseini, MS; Mehravi, B; Mirzaei, M; Mohseni, M; Naseripour, M, 2023
)
1.13

Dosage Studied

ExcerptRelevanceReference
" Animals were dosed 100 mg/kg capsaicin after the administration of olive oil, and the bile was obtained for 6 hours continuously after dosing with capsaicin for analysis of FFAs using HPLC methods."( Effects of capsaicin on biliary free fatty acids in rats.
Hori, Y; Nakamura, K; Saito, A; Yamamoto, M, 2000
)
0.31
" The colonic and plasma concentrations were analyzed by high performance liquid chromatography (HPLC) to evaluate colon-targeting action after oral administration of various dosage forms, and rebamipide with absorption enhancers in chitosan dosage forms."( Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier.
Akira, Y; Duan, L; Huang, BB; Li, GF; Luo, JH; Nobuaki, K, 2008
)
0.35
" In conclusion, current data confirmed that LA and CO exhibit strong antiprotozoal activity when dosed intraruminally, an effect that is accompanied by decreases in ammonia concentration and, for CO, lowered methane production."( Effect of lauric acid and coconut oil on ruminal fermentation, digestion, ammonia losses from manure, and milk fatty acid composition in lactating cows.
Agle, M; Hristov, AN; Johnson, K; Karnati, SK; Ndegwa, P; Schneider, C; Shingfield, KJ; Vaddella, VK; Vander Pol, M; Zaman, S, 2009
)
0.76
" In the main study, 6 lactating dairy cows were dosed intraruminally with 240 g/(cow · d) of stearic (SA, control), lauric (LA), or myristic (MA) acid in a replicated 3 × 3 Latin square design trial."( Rumen bacterial, archaeal, and fungal diversity of dairy cows in response to ingestion of lauric or myristic acid.
Callaway, TR; Dowd, SE; Hristov, AN; Lee, C, 2012
)
0.38
" Both agents showed high antiprotozoal activity when pulse dosed at these amounts via ruminal cannulae, reducing protozoa by 90% (P<0."( Effects of lauric acid on ruminal protozoal numbers and fermentation pattern and milk production in lactating dairy cows.
Broderick, GA; Faciola, AP; Hristov, A; Leão, MI, 2013
)
0.78
" Identification of organic chemical compounds extracted from eggs was performed using GC-MS and chemicals were tested in the same behavioral assays in a dose-response manner."( The egg and larval pheromone dodecanoic acid mediates density-dependent oviposition of Phlebotomus papatasi.
Apperson, CS; Hatano, E; Kowacich, D; Ponnusamy, L; Schal, C; Shymanovich, T; Wasserberg, G, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (33 Product(s))

Product Categories

Product CategoryProducts
Other9
Desserts2
Condiments, Sauces, Dips, Groceries2
Viandes et dérivés, Viandes, Poulet et dérivés, Volailles, Poulets, Filets de poulet1
Plantaardige levensmiddelen en dranken,Plantaardige levensmiddelen,Voedsel op basis van fruit en groenten,Kant-en-klaar maaltijden,Soepen,Crèmesoepen,Opwarmbare soepen,Paddestoelsoepen1
Condiments, Sauces, Moutardes1
Sandwiches, Doner kebab1
Produits de la mer, Poissons et dérivés, Poissons, Julienne salée sèche1
en:Plant-based foods and beverages, en:Plant-based foods, en:Snacks, en:Cereals and potatoes, en:Salty snacks, en:Appetizers, en:Chips and fries, en:Crisps, en:Potato crisps, en:Flavoured potato crisps1
M&S Pork Rib Rack1
Food & Beverages2
Household Essentials2
Beauty & Personal Care5
Professional Supplements1
Active Lifestyle & Fitness1
Baby & Kids Products2

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Fiesta Strawberry Puree, Wide-Mouth JugsDessertsSodium Benzoate,Propylene Glycol2024-02-11
Carrington Farms Gluten Free Coconut & Avocado Cooking Oil Blend -- 16 fl ozCarrington FarmsFood & BeveragesCapric Acid, Lauric Acid, Caprylic Acid2024-11-29 10:47:42
Carrington Farms Organic Coconut Cooking Oil Unflavored -- 16 fl ozCarrington FarmsFood & BeveragesCapric Acid, Lauric Acid, Caprylic Acid2024-11-29 10:47:42
Defunkify Laundry Detergent Liquid 62 Loads Fresh Air -- 37.7 fl ozDefunkifyHousehold Essentialsdecylglucoside, lauric acid, potassium hydroxide, propanediol, sodium carbonate, sodium citrate2024-11-29 10:47:42
Defunkify Laundry Detergent Liquid 62 Loads Lavender -- 37.7 fl ozDefunkifyHousehold Essentialsdecylglucoside, lauric acid, potassium hydroxide, propanediol, sodium carbonate, sodium citrate2024-11-29 10:47:42
Derma E Vitamin C Gentle Daily Cleansing Paste -- 4 ozDerma EBeauty & Personal Carebehenic acid, vitamin E, panthenol, vitamin E, glycerin, hydroxyethylcellulose, kaolin, lauric acid, myristic acid, palmitic acid, palmitic acid, potassium hydroxide, stearic acid, titanium dioxide2024-11-29 10:47:42
Dr. Mercola Mitomix™ Keto Organic MCT Oil -- 16 fl ozDr. MercolaProfessional SupplementsCapric Acid, Lauric Acid, Caprylic Acid2024-11-29 10:47:42
HiBar Cleanse Face Wash Bar Fragrance Free -- 2 ozHiBarBeauty & Personal Carealanine, arginine, aspartic acid, glycerin, glycine, histidine, isoleucine, lauric acid, phenylalanine, proline, propanediol, serine, sodium lactate, squalane, stearic acid, threonine, valine2024-11-29 10:47:42
HiBar Hydrate Face Wash Bar Fragrance Free -- 2 ozHiBarBeauty & Personal Carealanine, arginine, aspartic acid, panthenol, glycerin, glycine, histidine, isoleucine, lauric acid, phenylalanine, proline, propanediol, serine, sodium lactate, squalane, stearic acid, threonine, valine2024-11-29 10:47:42
HiBar Renew Face Wash Bar Fragrance Free -- 2 ozHiBarBeauty & Personal Carealanine, arginine, aspartic acid, glycerin, glycine, histidine, isoleucine, lauric acid, phenylalanine, proline, propanediol, serine, sodium lactate, squalane, stearic acid, threonine, undecylenic acid, valine2024-11-29 10:47:42
Onnit MCT Oil Unflavored -- 24 fl ozOnnitActive Lifestyle & Fitness Capric Acid, Lauric Acid, Caprylic Acid2024-11-29 10:47:42
SheaMoisture Baby Shampoo Nighttime Manuka Honey & Lavender -- 13 fl ozSheaMoistureBaby & Kids Productscaprylyl glycol, cocamidopropyl betaine, capric acid, lauric acid, caprylic acid, phenoxyethanol, sodium benzoate2024-11-29 10:47:42
SheaMoisture Men Raw Shea Butter & Mafura Oil Moisturizing Body Wash Cleanser -- 15 ozSheaMoistureBeauty & Personal Carecaprylyl glycol, citric acid, allantoin, citric acid, cocamidopropyl betaine, glycerin, lauric acid, sodium benzoate2024-11-29 10:47:42
The Honest Company New Mama Care Essentials Gift Set -- 1 SetThe Honest CompanyBaby & Kids Productscaprylyl glycol, citric acid, cellulose, cetearyl alcohol, cetyl alcohol, citric acid, tocopherol, tocopherol, glutamic acid, glycerin, glycolic acid, hectorite, microcrystalline cellulose, isopropyl palmitate, isostearyl alcohol, lactic acid, lauric acid, malic acid, maltodextrin, trisodium ethylenediamine disuccinate, propanediol, sodium benzoate, titanium dioxide2024-11-29 10:47:42

Roles (3)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
algal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in algae including unicellular organisms like chlorella and diatoms to multicellular organisms like giant kelps and brown algae.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
straight-chain saturated fatty acidAny saturated fatty acid lacking a side-chain.
medium-chain fatty acidAny fatty acid with a chain length of between C6 and C12.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (16)

PathwayProteinsCompounds
Metabolism14961108
Biological oxidations150276
Phase I - Functionalization of compounds69175
Cytochrome P450 - arranged by substrate type30110
Fatty acids010
Beta Oxidation of Very Long Chain Fatty Acids1013
Fatty Acid Biosynthesis233
Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids823
Adrenoleukodystrophy, X-Linked1013
Carnitine-Acylcarnitine Translocase Deficiency1013
Palmitate Biosynthesis1116
Fatty Acid Oxidation (Laurate)614
Omega-9 fatty acid synthesis226
Mitochondrial beta-oxidation064
Fatty acid omega-oxidation04
Omega-9 and other unsaturated fatty acids biosynthesis pathway017

Protein Targets (30)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency47.05210.007215.758889.3584AID1224835; AID588342
interleukin 8Homo sapiens (human)Potency74.97800.047349.480674.9780AID651758
glp-1 receptor, partialHomo sapiens (human)Potency3.98110.01846.806014.1254AID624417
AR proteinHomo sapiens (human)Potency13.72420.000221.22318,912.5098AID588516; AID743035; AID743042; AID743054; AID743063
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency14.12540.011212.4002100.0000AID1030
thyroid stimulating hormone receptorHomo sapiens (human)Potency19.91160.001318.074339.8107AID926; AID938
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency29.41610.000657.913322,387.1992AID1259377; AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency54.59350.001022.650876.6163AID1224838; AID1224893
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency5.49480.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency45.23160.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency43.03830.000817.505159.3239AID1159527; AID1159531; AID588544
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency47.72480.001530.607315,848.9004AID1259401
farnesoid X nuclear receptorHomo sapiens (human)Potency28.18380.375827.485161.6524AID588526
pregnane X nuclear receptorHomo sapiens (human)Potency6.30960.005428.02631,258.9301AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency43.63890.000229.305416,493.5996AID588513; AID743069; AID743075; AID743078; AID743079
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency48.18390.001024.504861.6448AID743212; AID743215; AID743227
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency47.35930.001019.414170.9645AID588537
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency30.97880.023723.228263.5986AID743222
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency48.65650.001723.839378.1014AID743083
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency19.496219.739145.978464.9432AID1159509
chromobox protein homolog 1Homo sapiens (human)Potency79.43280.006026.168889.1251AID540317
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency31.83260.010039.53711,122.0200AID588545; AID588547
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency62.42090.000323.4451159.6830AID743065; AID743067
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency31.62280.00798.23321,122.0200AID2551
Nuclear receptor ROR-gammaHomo sapiens (human)Potency48.33680.026622.448266.8242AID651802
Guanine nucleotide-binding protein GHomo sapiens (human)Potency31.62281.995325.532750.1187AID624287
Rap guanine nucleotide exchange factor 4Homo sapiens (human)Potency44.66843.981146.7448112.2020AID720708
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
G-protein coupled receptor 84Homo sapiens (human)Ki2.17000.02361.29013.3100AID1546369
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Free fatty acid receptor 1Homo sapiens (human)EC50 (µMol)6.72780.00030.73698.8000AID1308064; AID1308067; AID1416221
Free fatty acid receptor 4Homo sapiens (human)EC50 (µMol)7.58580.04372.35477.5858AID1416220
G-protein coupled receptor 84Homo sapiens (human)EC50 (µMol)8.47350.08903.868710.0000AID1416222; AID1416223; AID1546364; AID1546366; AID1707044; AID1707045
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (53)

Processvia Protein(s)Taxonomy
phospholipase C-activating G protein-coupled receptor signaling pathwayFree fatty acid receptor 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationFree fatty acid receptor 1Homo sapiens (human)
insulin secretionFree fatty acid receptor 1Homo sapiens (human)
negative regulation of interleukin-1 beta productionFree fatty acid receptor 1Homo sapiens (human)
glucose homeostasisFree fatty acid receptor 1Homo sapiens (human)
positive regulation of calcium ion transportFree fatty acid receptor 1Homo sapiens (human)
response to fatty acidFree fatty acid receptor 1Homo sapiens (human)
ion channel modulating, G protein-coupled receptor signaling pathwayFree fatty acid receptor 1Homo sapiens (human)
ligand-gated ion channel signaling pathwayFree fatty acid receptor 1Homo sapiens (human)
positive regulation of insulin secretionFree fatty acid receptor 1Homo sapiens (human)
G protein-coupled receptor signaling pathwayFree fatty acid receptor 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
renal water homeostasisGuanine nucleotide-binding protein GHomo sapiens (human)
G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein GHomo sapiens (human)
regulation of insulin secretionGuanine nucleotide-binding protein GHomo sapiens (human)
cellular response to glucagon stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
negative regulation of cytokine productionFree fatty acid receptor 4Homo sapiens (human)
inflammatory responseFree fatty acid receptor 4Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayFree fatty acid receptor 4Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayFree fatty acid receptor 4Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationFree fatty acid receptor 4Homo sapiens (human)
regulation of glucose transmembrane transportFree fatty acid receptor 4Homo sapiens (human)
negative regulation of interleukin-1 beta productionFree fatty acid receptor 4Homo sapiens (human)
ghrelin secretionFree fatty acid receptor 4Homo sapiens (human)
negative regulation of apoptotic processFree fatty acid receptor 4Homo sapiens (human)
positive regulation of osteoblast differentiationFree fatty acid receptor 4Homo sapiens (human)
negative regulation of inflammatory responseFree fatty acid receptor 4Homo sapiens (human)
white fat cell differentiationFree fatty acid receptor 4Homo sapiens (human)
brown fat cell differentiationFree fatty acid receptor 4Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of tasteFree fatty acid receptor 4Homo sapiens (human)
positive regulation of glucagon secretionFree fatty acid receptor 4Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeFree fatty acid receptor 4Homo sapiens (human)
negative regulation of somatostatin secretionFree fatty acid receptor 4Homo sapiens (human)
positive regulation of brown fat cell differentiationFree fatty acid receptor 4Homo sapiens (human)
positive regulation of cold-induced thermogenesisFree fatty acid receptor 4Homo sapiens (human)
cellular response to hormone stimulusFree fatty acid receptor 4Homo sapiens (human)
G protein-coupled receptor signaling pathwayFree fatty acid receptor 4Homo sapiens (human)
hormone secretionFree fatty acid receptor 4Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 4Homo sapiens (human)
G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
calcium-ion regulated exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
positive regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of synaptic vesicle cycleRap guanine nucleotide exchange factor 4Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
biological_processG-protein coupled receptor 84Homo sapiens (human)
neuropeptide signaling pathwayG-protein coupled receptor 84Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (23)

Processvia Protein(s)Taxonomy
G protein-coupled receptor activityFree fatty acid receptor 1Homo sapiens (human)
lipid bindingFree fatty acid receptor 1Homo sapiens (human)
bioactive lipid receptor activityFree fatty acid receptor 1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
G protein activityGuanine nucleotide-binding protein GHomo sapiens (human)
adenylate cyclase activator activityGuanine nucleotide-binding protein GHomo sapiens (human)
G protein-coupled receptor activityFree fatty acid receptor 4Homo sapiens (human)
fatty acid bindingFree fatty acid receptor 4Homo sapiens (human)
taste receptor activityFree fatty acid receptor 4Homo sapiens (human)
peptide bindingFree fatty acid receptor 4Homo sapiens (human)
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein-macromolecule adaptor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
small GTPase bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
urotensin II receptor activityG-protein coupled receptor 84Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (16)

Processvia Protein(s)Taxonomy
plasma membraneFree fatty acid receptor 1Homo sapiens (human)
plasma membraneFree fatty acid receptor 1Homo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
plasma membraneGuanine nucleotide-binding protein GHomo sapiens (human)
lysosomal membraneFree fatty acid receptor 4Homo sapiens (human)
plasma membraneFree fatty acid receptor 4Homo sapiens (human)
ciliumFree fatty acid receptor 4Homo sapiens (human)
endosome membraneFree fatty acid receptor 4Homo sapiens (human)
endocytic vesicleFree fatty acid receptor 4Homo sapiens (human)
ciliary membraneFree fatty acid receptor 4Homo sapiens (human)
plasma membraneFree fatty acid receptor 4Homo sapiens (human)
cytosolRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneG-protein coupled receptor 84Homo sapiens (human)
specific granule membraneG-protein coupled receptor 84Homo sapiens (human)
tertiary granule membraneG-protein coupled receptor 84Homo sapiens (human)
receptor complexG-protein coupled receptor 84Homo sapiens (human)
plasma membraneG-protein coupled receptor 84Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (99)

Assay IDTitleYearJournalArticle
AID1308065Agonist activity at human C-terminal eYFP-tagged FFA1 receptor expressed in HEK-293 cells assessed as beta-arrestin2 recruitment incubated for 5 mins by BRET assay relative to TUG-7702016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
Development and Characterization of a Potent Free Fatty Acid Receptor 1 (FFA1) Fluorescent Tracer.
AID334998Antimicrobial activity against Candida utilis ATCC 9226 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1417295Inhibition of electric eel AChE at 10 M using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured at 1 min intervals for 30 mins by Ellman's method2018Bioorganic & medicinal chemistry letters, 11-01, Volume: 28, Issue:20
Unexpected AChE inhibitory activity of (2E)α,β-unsaturated fatty acids.
AID334999Antimicrobial activity against Pityrosporum ovale ATCC 14521 by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID624611Specific activity of expressed human recombinant UGT1A82000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1083135Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 2000 umol/L on day 3 (SDW control = 0.57 +/- 0.37%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1083137Nematicidal activity against Meloidogyne incognita (root-knot nematode) root-knot nematodes assessed as cumulative percentage of egg hatching at 25 degC at 100 umol/L on day 3 (SDW control = 0.57 +/- 0.37%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID627982Antiinflammatory activity in mouse assessed as inhibition of TPA-induced mouse ear edema at 500 ug/ear administered 30 mins before TPA challenge measured after 7 hrs relative to untreated control2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID1083131Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 100 umol/L on day 14 (SDW control = 35.77 +/- 4.48%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1308064Agonist activity at human C-terminal eYFP-tagged FFA1 receptor expressed in HEK-293 cells assessed as beta-arrestin2 recruitment incubated for 5 mins by BRET assay2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
Development and Characterization of a Potent Free Fatty Acid Receptor 1 (FFA1) Fluorescent Tracer.
AID332912Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method1994Journal of natural products, Jan, Volume: 57, Issue:1
Naturally occurring antiacne agents.
AID334996Antimicrobial activity against Enterobacter aerogenes ATCC 13048 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1083127Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 1000 umol/L on day 21 (SDW control = 44.87 +/- 3.93%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID334997Antimicrobial activity against Saccharomyces cerevisiae ATCC 7754 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1308063Displacement of 3-(2-Fluoro-4-((2'-methyl-4'-(2-(2-((7-nitrobenzo[c][1,2,5]-oxadiazol-4-yl)amino)ethoxy)ethoxy)-[1,1'-biphenyl]-3-yl)-methoxy)phenyl)propanoic acid from N-terminal NLUC-tagged FFA1 receptor (unknown origin) expressed in human Flp-In T-REX-2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
Development and Characterization of a Potent Free Fatty Acid Receptor 1 (FFA1) Fluorescent Tracer.
AID1083132Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 2000 umol/L on day 7 (SDW control = 12.63 +/- 3.84%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1546366Agonist activity at recombinant human GPR84 expressed in CHO cell membranes co-expressing beta-arrestin2 assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation preincubated for 5 mins followed by forskolin stimulation and measured after 15 m2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
An Agonist Radioligand for the Proinflammatory Lipid-Activated G Protein-Coupled Receptor GPR84 Providing Structural Insights.
AID1308067Agonist activity at FFA1 receptor (unknown origin) expressed in human 132N1 cells measured for 90 secs by Fura-2 AM dye based calcium mobilization assay2016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
Development and Characterization of a Potent Free Fatty Acid Receptor 1 (FFA1) Fluorescent Tracer.
AID597407Antibacterial activity against Staphylococcus aureus by broth microdilution method2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Comparing micellar, hemolytic, and antibacterial properties of di- and tricarboxyl dendritic amphiphiles.
AID1707045Agonist activity at human GPR84 expressed in CHO cell membranes assessed as induction of [35S]GTPgammaS incorporation incubated for 1 hr by liquid scintillation counting method2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Modulation of the G-Protein-Coupled Receptor 84 (GPR84) by Agonists and Antagonists.
AID1416220Agonist activity at N-terminal FLAG-tagged/C-terminal eYFP-fused human FFA4 receptor expressed in HEK293T cells assessed as induction of beta-arrestin-2 recruitment after 5 mins by BRET assay2017MedChemComm, Jun-01, Volume: 8, Issue:6
Succinct synthesis of saturated hydroxy fatty acids and
AID627880Inhibition of recombinant His-tagged human DNA polymerase lambda using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID40623Inhibitory activity on germination of Bacillus subtilis PCI219 spores was determined.1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID627981Cytotoxicity against mouse RAW264.7 cells2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID628060Inhibition of recombinant His-tagged human DNA polymerase lambda using poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID627874Inhibition of calf DNA polymerase alpha using poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID1083130Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 1000 umol/L on day 14 (SDW control = 35.77 +/- 4.48%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID334993Antimicrobial activity against Streptococcus mutans ATCC 25175 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID627976Cytotoxicity against human HCT116 cells by WST-1 assay2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID627878Inhibition of histidine-tagged human DNA polymerase gamma using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID627980Cytotoxicity against mouse RAW264.7 cells at 5 uM2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID164418Sterilization time for contact germicidal efficiency (CGE) of salt was tested against Pseudomonas aeruginosa at pH 7.0, concentration 610 ppm1980Journal of medicinal chemistry, May, Volume: 23, Issue:5
Soft drugs. 1. Labile quaternary ammonium salts as soft antimicrobials.
AID1546364Agonist activity at recombinant human GPR84 expressed in CHO cell membranes co-expressing beta-arrestin2 assessed as beta-arrestin 2 recruitment measured after 90 mins by beta-galactosidase based PathHunter assay2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
An Agonist Radioligand for the Proinflammatory Lipid-Activated G Protein-Coupled Receptor GPR84 Providing Structural Insights.
AID40935Inhibition of Bacillus subtilis spore germination, activity is expressed as log of the reciprocal of Casida's I50 value.1983Journal of medicinal chemistry, Sep, Volume: 26, Issue:9
Ion-sensitive electrode potentiometry of organic anions: application to quantitative structure-activity relationships.
AID1416222Agonist activity at N-terminal FLAG-tagged/C-terminal eYFP-fused human GPR84 expressed in CHO cell membranes assessed as induction of [35S]GTPgammaS binding after 1 hr by liquid scintillation counting method2017MedChemComm, Jun-01, Volume: 8, Issue:6
Succinct synthesis of saturated hydroxy fatty acids and
AID627876Inhibition of C-terminal His6-tagged human DNA polymerase kappa (amino acids 1 to 560) using poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID1083124Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 100 umol/L after 24 hr (Rvb = 1.47 to 2.51%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID40936Inhibition of Bacillus subtilis PCI219 spore germination, expressed as log 1/I501982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID1083129Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 2000 umol/L on day 14 (SDW control = 35.77 +/- 4.48%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1546370Agonist activity at recombinant human GPR84 expressed in CHO cell membranes co-expressing beta-arrestin2 assessed as beta-arrestin 2 recruitment measured after 90 mins by beta-galactosidase based PathHunter assay relative to embelin2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
An Agonist Radioligand for the Proinflammatory Lipid-Activated G Protein-Coupled Receptor GPR84 Providing Structural Insights.
AID1707044Agonist activity at human GPR84 expressed in CHO cells assessed as reduction in forskolin-stimulated cAMP production preincubated for 20 mins followed by forskolin stimulation and measured after 20 mins by cAMP assay2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Modulation of the G-Protein-Coupled Receptor 84 (GPR84) by Agonists and Antagonists.
AID1416224Agonist activity at N-terminal FLAG-tagged/C-terminal eYFP-fused human GPR84 expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation up to 100 uM preincubated for 20 mins followed by forskolin-induction and measured a2017MedChemComm, Jun-01, Volume: 8, Issue:6
Succinct synthesis of saturated hydroxy fatty acids and
AID1081323Nematicidal activity against Bursaphelenchus xylophilus at 0.5 mg/ml measured after 48 hr under microscope2010Journal of agricultural and food chemistry, Feb-10, Volume: 58, Issue:3
Structure-activity relationship of aliphatic compounds for nematicidal activity against pine wood nematode (Bursaphelenchus xylophilus).
AID403754Antitubercular activity against Mycobacterium tuberculosis 90-2213872005Journal of natural products, Sep, Volume: 68, Issue:9
Antitubercular constituents from the stem wood of Cinnamomum kotoense.
AID597408Antibacterial activity against methicillin-resistant Staphylococcus aureus by broth microdilution method2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Comparing micellar, hemolytic, and antibacterial properties of di- and tricarboxyl dendritic amphiphiles.
AID627877Inhibition of calf DNA polymerase alpha using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID1546365Agonist activity at recombinant human GPR84 expressed in CHO cell membranes co-expressing beta-arrestin2 assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation preincubated for 5 mins followed by forskolin stimulation and measured after 15 m2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
An Agonist Radioligand for the Proinflammatory Lipid-Activated G Protein-Coupled Receptor GPR84 Providing Structural Insights.
AID334990Antimicrobial activity against Brevibacterium ammoniagenes ATCC 6872 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID334989Antimicrobial activity against Bacillus subtilis ATCC 9372 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1308068Agonist activity at FFA1 receptor (unknown origin) expressed in human 132N1 cells measured for 90 secs by Fura-2 AM dye based calcium mobilization assay relative to TUG-7702016Journal of medicinal chemistry, 05-26, Volume: 59, Issue:10
Development and Characterization of a Potent Free Fatty Acid Receptor 1 (FFA1) Fluorescent Tracer.
AID627875Inhibition of histidine-tagged human DNA polymerase gamma using poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID210082Sterilization time for contact germicidal efficiency (CGE) of salt was tested against Streptococcus pyogenes at pH 7.0, concentration 610 ppm1980Journal of medicinal chemistry, May, Volume: 23, Issue:5
Soft drugs. 1. Labile quaternary ammonium salts as soft antimicrobials.
AID1416221Agonist activity at N-terminal FLAG-tagged/C-terminal eYFP-fused human FFA1 receptor expressed in Flp-In T-Rex 293 cells assessed as induction of Ca2+ mobilization after 45 mins by Fura2-AM dye-based fluorescence assay2017MedChemComm, Jun-01, Volume: 8, Issue:6
Succinct synthesis of saturated hydroxy fatty acids and
AID624613Specific activity of expressed human recombinant UGT1A102000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1083120Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 2000 umol/L after 24 hr Rvb = 1.47 to 2.51%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID334995Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID25611Dissociation constant (pKa)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID390912Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 after 24 hrs by macrobroth dilution method2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Design, synthesis, and antibacterial activities of neomycin-lipid conjugates: polycationic lipids with potent gram-positive activity.
AID1083126Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 2000 umol/L on day 21 (SDW control = 44.87 +/- 3.93%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID390920Antibacterial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by macrobroth dilution method2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Design, synthesis, and antibacterial activities of neomycin-lipid conjugates: polycationic lipids with potent gram-positive activity.
AID334994Antimicrobial activity against Escherichia coli ATCC 9637 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID26793Partition coefficient (logP)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID1083121Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 2000 umol/L after 12 hr (Rvb = 1.79 to 3.30%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1083133Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 1000 umol/L on day 7 (SDW control = 12.63 +/- 3.84%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID492140Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds.
AID334991Antimicrobial activity against Propionibacterium acnes ATCC 11827 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1417297Inhibition of equine serum BuChE at 10 M using butyrylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured at 1 min intervals for 30 mins by Ellman's method2018Bioorganic & medicinal chemistry letters, 11-01, Volume: 28, Issue:20
Unexpected AChE inhibitory activity of (2E)α,β-unsaturated fatty acids.
AID1546369Displacement of [3H]PSB-1584 from recombinant human GPR84 expressed in CHO cell membranes co-expressing beta-arrestin2 measured after 6 hrs by scintillation counting method2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
An Agonist Radioligand for the Proinflammatory Lipid-Activated G Protein-Coupled Receptor GPR84 Providing Structural Insights.
AID1083123Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 1000 umol/L after 12 hr (Rvb = 1.79 to 3.30%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1083136Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 1000 umol/L on day 3 (SDW control = 0.57 +/- 0.37%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1416223Agonist activity at N-terminal FLAG-tagged/C-terminal eYFP-fused human GPR84 expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation preincubated for 20 mins followed by forskolin-induction and measured after 20 mins2017MedChemComm, Jun-01, Volume: 8, Issue:6
Succinct synthesis of saturated hydroxy fatty acids and
AID334992Antimicrobial activity against Staphylococcus aureus ATCC 12598 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID624607Specific activity of expressed human recombinant UGT1A32000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1123305Cytotoxicity against HGPRTase-deficient mouse S49 cells assessed as growth inhibition at 100 uM after 72 hrs by trypan blue exclusion assay1979Journal of medicinal chemistry, Jul, Volume: 22, Issue:7
2'-O-Acyl-6-thioinosine cyclic 3',5'-phosphates as prodrugs of thioinosinic acid.
AID627979Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha secretion at 5 uM treated 30 mins before LPS challenge measured after 24 hrs by ELISA2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID1083134Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 100 umol/L on day 7 (SDW control = 12.63 +/- 3.84%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID335000Antimicrobial activity against Penicillium chrysogenum ATCC 10106 after 5 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1083128Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 100 umol/L on day 21 (SDW control = 44.87 +/- 3.93%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1083125Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 100 umol/L after 12 hr (Rvb = 1.79 to 3.30%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1083122Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 1000 umol/L after 24 hr Rvb = 1.47 to 2.51%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID721491Immunostimulatory activity in ICR mouse macrophage assessed as induction of phagocytic activity at 50 uM after 2 hrs by fluorescent microsphere assay2013Journal of medicinal chemistry, Jan-10, Volume: 56, Issue:1
Development of vizantin, a safe immunostimulant, based on the structure-activity relationship of trehalose-6,6'-dicorynomycolate.
AID26261Partition coefficient (logD7.2)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID627879Inhibition of C-terminal His6-tagged human DNA polymerase kappa (amino acids 1 to 560) using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID207085Sterilization time for contact germicidal efficiency (CGE) of salt was tested against Staphylococcus aureus at pH 7.0, concentration 610 ppm1980Journal of medicinal chemistry, May, Volume: 23, Issue:5
Soft drugs. 1. Labile quaternary ammonium salts as soft antimicrobials.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1345177Human GPR84 (Class A Orphans)2006The Journal of biological chemistry, Nov-10, Volume: 281, Issue:45
Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2013Archives of biochemistry and biophysics, Jan-01, Volume: 529, Issue:1
Structural basis of the binding of fatty acids to peptidoglycan recognition protein, PGRP-S through second binding site.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (902)

TimeframeStudies, This Drug (%)All Drugs %
pre-199090 (9.98)18.7374
1990's194 (21.51)18.2507
2000's245 (27.16)29.6817
2010's283 (31.37)24.3611
2020's90 (9.98)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 79.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index79.92 (24.57)
Research Supply Index6.87 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index149.45 (26.88)
Search Engine Supply Index2.10 (0.95)

This Compound (79.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials38 (4.13%)5.53%
Reviews13 (1.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (0.11%)0.25%
Other869 (94.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]